Dennis Cook

The transition to value-based healthcare is inevitable. Providers need to plan now to acquire the technology and set up the training needed to make it work. Learn more: https://lnkd.in/gWfqxj4n

A “grand experiment” — 100 years in the making. Managing Partner Jim Proppe reflects on our founders’ vision and how it remains at the core of who we are. Read here to learn how these principles have guided our growth. #CountOnUs #100years #PlanteMoranProud https://okt.to/HKGcND

Hood River Capital Management LLC Acquires 15,899 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by Defense World Staff via Defense World ([Global] oracle cloud) URL: https://ift.tt/1RGujfo Hood River Capital Management LLC boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 243,897 shares of the company’s stock after acquiring an additional 15,899 shares during the period. Hood River Capital Management LLC owned 0.24% of Neurocrine Biosciences worth $33,577,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds have also added to or reduced their stakes in the business. RFP Financial Group LLC increased its holdings in shares of Neurocrine Biosciences by 346.5% during the first quarter. RFP Financial Group LLC now owns 192 shares of the company’s stock worth $26,000 after purchasing an additional 149 shares during the period. Mather Group LLC. acquired a new stake in Neurocrine Biosciences during the first quarter worth approximately $26,000. Ashton Thomas Private Wealth LLC bought a new position in Neurocrine Biosciences during the 2nd quarter worth $28,000. Innealta Capital LLC acquired a new position in Neurocrine Biosciences in the 2nd quarter valued at $30,000. Finally, New Covenant Trust Company N.A. bought a new stake in shares of Neurocrine Biosciences during the 1st quarter valued at $32,000. Institutional investors and hedge funds own 92.59% of the company’s stock. Insider Buying and Selling In other Neurocrine Biosciences news, insider Julie Cooke sold 900 shares of the stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $150.04, for a total transaction of $135,036.00. Following the completion of the sale, the insider now owns 18,202 shares of the company’s stock, valued at approximately $2,731,028.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Neurocrine Biosciences news, insider Julie Cooke sold 900 shares of the company’s stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $150.04, for a total transaction of $135,036.00. Following the sale, the insider now owns 18,202 shares of the company’s stock, valued at $2,731,028.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William H. Rastetter sold 14,250 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $146.69, for a total value of $2,090,332.50. Following the sale, the director now owns 37,491 shares of the company’s stock, valued at $5,499,554.79. The disclosure for this sale can be...

Tune in to our latest podcast episode on Core Web Vitals! Learn how these metrics impact user experience and SEO rankings. #EdgioPodcast #CoreWebVitals

The US Electronic Medical Records Market to Hit $8.10 Billion by 2029, Modernization of Healthcare Creating Huge Demand for EMR – Arizton      by admin via ABNewswire ([Global] oracle cloud) URL: https://ift.tt/QNE9YaM U.S. Electronic Medical Records (EMR) Market Research Report by Arizton  According to Arizton’s latest research report, the US electronic medical records (EMR) market is growing at a CAGR of 5.35% during 2023-2029.          To Know More, Click: https://ift.tt/Qz2t3hu     Report Summary                Market Size (2029): $8.10 Billion  Market Size (2023): $5.92 Billion  CAGR (2023-2029): 5.35%      Historic Year: 2020-2022           Base Year: 2023           Forecast Year: 2024-2029      Market Segmentation: Development, Component, Application, and End-User              Stay ahead of the curve with Arizton’s exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month—a significant value compared to individual report purchases. Click here: https://lnkd.in/gA48qwDB             The Rise of EMR Systems in Modern Healthcare Creating Market Expansion  The adoption of Electronic Medical Record (EMR) systems has surged in healthcare settings over the past decade. Due to federal funding and legislation mandating the adoption of EMR systems, over 96% of hospitals and physicians had transitioned to digital systems by 2023, a significant leap from less than 10% in 2010. This shift reflects an evolving healthcare landscape where EMR providers are increasingly vital. Demographic and economic factors have driven the widespread use of EMRs, and their benefits—such as cost savings, enhanced security, and improved coordination—underscore the superiority of digital records over paper-based ones. EMRs have become integral to the more digital healthcare environment of today. Most health systems now rely on EMR systems for their ability to enhance security, patient outcomes, and overall efficiency. Innovators continue to push the boundaries at this digital frontier, demonstrating how EMRs can contribute to safer, more effective, and more affordable healthcare.    Segmentation Insights  Insights by Development Type  The U.S. electronic medical records (EMR) market is segmented by development type, with the web/cloud-based EMR segment leading the 2023 market, capturing over 62% of the share. The growing digitalization of healthcare is fueling the demand for cloud-based EMR solutions and the adoption of cloud-based healthcare systems. These solutions require minimal upfront investment, offer high scalability, and are easily accessible. However, security concerns persist, and healthcare organizations must carefully weigh factors such as cost, security, accessibility, and scalability when choosing cloud-based EMRs.  Insights by End-User Type  The specialized clinics segment is experiencing significant growth, with the highest compound an...